Melinta up 20% premarket

|About: Melinta Therapeutics (MLNT)|By:, SA News Editor

Nano cap Melinta Therapeutics (NASDAQ:MLNT) is up 20% premarket on increased volume following yesterday's corporate update.

Sales for Q4 and 2018 should come in at ~$14M and ~$46M, respectively.

Subscribe for full text news in your inbox